Muramyldipeptide modulates CXCL-8 release of BEAS-2B cells via NOD2

L Farkas1, B Stoelcker, N Jentsch

  • 1Klinik und Poliklinik für Innere Medizin II, Universität Regensburg, Regensburg, Germany. laszlo.farkas@klinik.uni-regensburg.de

Insights

Nucleotide oligomerization domain 2 (NOD2) and muramyldipeptide (MDP) are crucial for CXCL-8 release in bronchial cells. Their interaction with lipopolysaccharide (LPS) influences immune responses in chronic obstructive pulmonary disease (COPD).

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Chronic obstructive pulmonary disease (COPD) involves chronic inflammation and impaired immune responses.
  • Nucleotide oligomerization domain 2 (NOD2) is an innate immune receptor for muramyldipeptide (MDP), and its dysfunction is linked to inflammatory diseases.
  • NOD2 gene mutations can lead to decreased MDP recognition, contributing to intestinal inflammation and pulmonary complications.

Purpose of the Study:

  • To investigate the role of NOD2, toll-like receptor 4 (TLR4), and receptor-interacting protein 2 (RIP2) in bronchial epithelial cells.
  • To elucidate the mechanisms by which tumor-necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) influence these immune receptors.
  • To examine the synergistic effects of MDP and lipopolysaccharide (LPS) on CXCL-8 chemokine release.

Main Methods:

  • Utilized the bronchial epithelial cell line BEAS-2B.
  • Investigated the induction of NOD2, TLR4, and RIP2 by TNF-alpha and IFN-gamma.
  • Assessed the impact of LPS on NOD2 transcription in cytokine-primed cells.
  • Measured CXCL-8 release following stimulation with MDP and/or LPS.
  • Compared chemokine production in cells overexpressing wild-type NOD2 versus an SNP13 mutant.

Main Results:

  • TNF-alpha and IFN-gamma induce NOD2, TLR4, and RIP2 in BEAS-2B cells.
  • LPS further increases NOD2 transcription in cytokine-activated cells.
  • MDP alone does not enhance CXCL-8 release, but primes cells for increased secretion after TNF-alpha/IFN-gamma pre-stimulation via NOD2/RIP2.
  • LPS significantly increases CXCL-8 production, with MDP co-administration further augmenting secretion.
  • Overexpression of an SNP13 NOD2 mutant reduces MDP-induced chemokine production compared to wild-type NOD2.

Conclusions:

  • MDP and NOD2 play a significant role in CXCL-8 release from bronchial epithelial cells upon LPS challenge.
  • Synergistic interactions between MDP and LPS are critical for modulating immune responses in the airways.
  • These findings highlight the complex interplay of innate immune receptors and bacterial components in COPD pathogenesis.

Related Concept Videos